Snellgrove Oliver
Intensive Care Unit Hornsby Hospital Hornsby New South Wales Australia.
Clin Case Rep. 2017 Feb 1;5(3):268-269. doi: 10.1002/ccr3.809. eCollection 2017 Mar.
Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life-threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used in the management of HIT.
阿哌沙班是一种相对较新的药物，其安全性仍在确定之中。血小板减少症是一种罕见但危及生命的副作用，此前尚无相关病例报道。临床医生必须对此有所了解并谨慎使用，特别是因为一些研究暗示它可能用于治疗肝素诱导的血小板减少症（HIT）。
